• Explore /
  • Poster
  • / A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.

A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.

Abstract Poster

Authors

Julie Koenig

Julie L. Koenig

Harvard Radiation Oncology Program, Boston, MA

Julie L. Koenig , Leon Pappas , Beow Y. Yeap , Jeffrey William Clark , Colin D. Weekes , Jill N. Allen , Lawrence Scott Blaszkowsky , David P. Ryan , James M. Cleary , Joseph Douglas Mancias , Benjamin L. Schlechter , Sarah Elizabeth Slater , Jennifer Yon-Li Wo , Hannah Johnson Roberts , Sofia Von Fedak , Nicole Carzo , Lorraine C. Drapek , Arnav Mehta , Theodore S. Hong , Aparna Raj Parikh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04361162

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4143)

DOI

10.1200/JCO.2023.41.16_suppl.4143

Abstract #

4143

Poster Bd #

464

Abstract Disclosures

Similar Posters

First Author: Julie L. Koenig

First Author: Lorenzo Pilla

First Author: Aparna Raj Parikh

Poster

2019 Gastrointestinal Cancers Symposium

A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.

A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.

First Author: Aparna Parikh